Quantinno Capital Management LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1759654 NEW YORK, NY

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,374,530

+$612,350 QoQ

Shares Held

137,453

+71.7% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#107

of 316 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. BCRX ranks #20 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	1,974,908	$48,602,485
2	ZTS	Zoetis Inc.	400,665	$28,791,786
3	TAK	Takeda Pharmaceutical Co Ltd	1,402,650	$22,484,479
4	VTRS	Viatris Inc	1,368,433	$21,730,716
5	UTHR	UNITED THERAPEUTICS Corp	27,122	$14,695,513
6	PRGO	PERRIGO Co plc	1,369,736	$14,231,557
7	NBIX	Neurocrine Biosciences Inc	79,655	$13,425,053
8	HLN	Haleon plc	1,151,189	$10,740,593

All Filings in BCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,374,530	137,453	+71.7%	Shares	Sole	2026-08-13
2026-03-31	$762,180	80,061	+245.8%	Shares	Sole	2026-05-15
2025-12-31	$180,585	23,152	-21.6%	Shares	Sole	2026-02-17
2025-09-30	$224,064	29,521	+54.2%	Shares	Sole	2025-11-14
2025-06-30	$171,548	19,146	+13.6%	Shares	Sole	2025-08-14
2025-03-31	$126,450	16,860	+13.7%	Shares	Sole	2025-05-12
2024-12-31	$111,506	14,828	+38.2%	Shares	Sole	2025-02-14
2024-09-30	$81,555	10,731	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.